Is a Breast Cancer Treatment a Sleeper Blockbuster for Nuvilex?

When one lifts up the hood, one realizes that a sleeping giant in the form of highly successful animal trials to treat mammary tumors may emerge as a real blockbuster for Nuvilex.

Read more...
 
INSCOR On Track With Ghana Initiative

With the return of its CEO from a highly successful trip in Ghana, INSCOR, Inc. (OTCQB – IOGA – Spec Buy), along with the other partners associated with an impressive mass social welfare initiative, is gearing up for the 4Q13 launch of the program, which could eventually encompass as many as 650 million living in poverty in Africa.

Read more...
 
Would Detroit Have Failed If It Used INSCOR’s Financial Solutions?

While it may be too late for most of these other cities to utilize the INSCOR initiatives, hundreds of others may finally become proactive and seek out the Company and its offerings to stave off a fiscal crisis.

Read more...
 
Nuvilex Is the Rodney Dangerfield of Biotechs

Let’s face it, the Company gets no respect. That is all about to change. In fact, we predict that Nuvilex will ultimately turn from Rodney Dangerfield into Cinderella.

Read more...
 
Carbon Offset Firm Offers Tremendous Value
With some of the largest and most sought after property in the carbon offset arena, we believe that this carbon offset pure play is worth more than its $6.72 book value.
Read more...
 
Plandaí’s Phytofare™ Catechin Complex to Fight Child Obesity

Plandaí Biotechnology, Inc. (OTCQB – PLPL - $0.53 - Spec Buy), which is slated engage in a weight loss study to test the efficacy of its flagship product, is well-positioned to assist in the fight against child obesity.

Read more...
 
Major Achievements Set Stage for Big 2014
Nuvilex’s just released shareholder update indicates that recent and pending milestones set the stage for a big 2014 for the Company.
Read more...
 
LifeApps Is Transforming Lucrative Digital Branding Industry

The unique LifeApps business model will be a catalyst for companies in the sports industry to develop strong brands and reach more consumers via digital media, driving major top-line growth and future profits.

Read more...
 
Plandaí’s Upcoming Weight Loss Study Primed to Outperform Competing Trials

With all of these positive attributes in its corner, Plandaí is on the verge of changing how we approach weight loss on its way to generating substantial revenue in the nutriceutical space.

Read more...
 
A Five-Bagger is in the Cards

LIG Assets (OTCPK – LIGA) is a near term 5-bagger. The stock trades .7x its recently affirmed $7.5M book value and should earn $3-4M this year in net income. Moreover, with a series of major events in milestones in the near term, including funding, these catalytic events should drive the stock markedly higher.

Read more...
 
<< Start < Prev 31 32 33 34 35 36 37 38 39 40 Next > End >>

Page 34 of 47